Quality of the estimate. December, p. 47 - Health Care Compliance ...
Quality of the estimate. December, p. 47 - Health Care Compliance ...
Quality of the estimate. December, p. 47 - Health Care Compliance ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Community Relations. A process<br />
to reduce <strong>the</strong> time to review and<br />
translate <strong>the</strong> documents was<br />
developed during 2009. The<br />
review <strong>of</strong> <strong>the</strong> process was initiated<br />
because our collaborative research<br />
partner institutions expressed<br />
concern that <strong>the</strong>re was significant<br />
variability in <strong>the</strong> process. This was<br />
due, in part, to <strong>the</strong> review <strong>of</strong> <strong>the</strong><br />
protocols and translation <strong>of</strong> documents<br />
among separate partner or<br />
collaborator IRBs.<br />
After <strong>the</strong> execution <strong>of</strong> a Memorandum<br />
<strong>of</strong> Understanding for<br />
Research and Graduate Education<br />
Partnerships between MIHS<br />
and a partner university, an<br />
IRB reciprocity agreement was<br />
executed that determines IRB<br />
authority over joint research<br />
programs where clinical research<br />
is conducted solely at MIHS. By<br />
stipulating that MIHS would<br />
be <strong>the</strong> IRB <strong>of</strong> record, <strong>the</strong> agreement<br />
ensured <strong>the</strong>re would be a<br />
single review <strong>of</strong> <strong>the</strong> protocols and<br />
translation <strong>of</strong> documents, which<br />
has resulted in a significant reduction<br />
in <strong>the</strong> time needed for review<br />
and approval. For o<strong>the</strong>r partner<br />
institutions, master agreements<br />
were executed that stipulated <strong>the</strong><br />
IRB <strong>of</strong> record and authority for<br />
translated documents, resulting<br />
in greater efficiency for approving<br />
individual research agreements.<br />
Step 4: Contracts and billing<br />
All financial activities related to<br />
clinical research were centralized<br />
during <strong>the</strong> Department <strong>of</strong><br />
Research’s second year <strong>of</strong> operation.<br />
Accountabilities and controls<br />
were developed to ensure invoicing<br />
uniformity for all research<br />
studies with billable items and<br />
services, as well as research billing<br />
compliance throughout MIHS.<br />
All grant and contract-related<br />
budgets are initially processed<br />
through <strong>the</strong> Department <strong>of</strong><br />
Research for prospective reimbursement<br />
analysis, budget<br />
development, and budget negotiation.<br />
In addition, <strong>the</strong> post-award<br />
team is charged with <strong>the</strong> review<br />
<strong>of</strong> billing issues and developing<br />
a process for invoicing for each<br />
study. At <strong>the</strong> time that <strong>the</strong> author<br />
assumed his current position<br />
(Director <strong>of</strong> <strong>the</strong> Department <strong>of</strong><br />
Research) <strong>the</strong>re was no specific<br />
plan for cost accountability or cost<br />
recovery for <strong>the</strong> department and<br />
its activities.<br />
The first step towards a full accounting<br />
was to realign <strong>the</strong> administrative<br />
structure (see Step 1) to reflect <strong>the</strong><br />
principle differences in cost recovery<br />
for <strong>the</strong> activities <strong>of</strong> <strong>the</strong> department.<br />
The industry-sponsored<br />
Contracts and Clinical Trial Oversight<br />
division is responsible for<br />
activities that can provide a stable<br />
stream <strong>of</strong> income that is over and<br />
above <strong>the</strong> cost <strong>of</strong> administering<br />
<strong>the</strong> activities <strong>of</strong> this division. This<br />
occurs through direct costs billed<br />
to <strong>the</strong> clinical trials for <strong>the</strong> clinical<br />
research coordinator (CRC) staff<br />
and <strong>the</strong> indirect rate cost recovery<br />
<strong>Health</strong> <strong>Care</strong> <strong>Compliance</strong> Association • 888-580-8373 • www.hcca-info.org<br />
from each clinical trial managed by<br />
<strong>the</strong> Department <strong>of</strong> Research. The<br />
goal for each budget year is to add<br />
CRC staffing only as <strong>the</strong> income<br />
generated from <strong>the</strong> clinical trials is<br />
able to fully support <strong>the</strong> additional<br />
positions. Obviously, bottlenecks<br />
during any step <strong>of</strong> <strong>the</strong> process,<br />
from initial contact by <strong>the</strong> clinical<br />
research organization (CRO)/sponsor,<br />
through contract negotiations,<br />
recruitment issues, and physician<br />
oversight, limits growth in research<br />
activities and income. To reduce<br />
<strong>the</strong> amount <strong>of</strong> time required for<br />
contract negotiation and to simultaneously<br />
improve consistency<br />
in <strong>the</strong> process, we worked with<br />
district legal counsel to develop a<br />
master language guide that detailed<br />
<strong>the</strong> information that was required<br />
to be included in any research contract.<br />
Each contract is reviewed for<br />
conformity and compliance with<br />
<strong>the</strong> template, including intellectual<br />
property protection language,<br />
and <strong>the</strong>n submitted with a list <strong>of</strong><br />
proposed changes in language for<br />
review by legal counsel. An edited<br />
research contract is developed in a<br />
short period <strong>of</strong> time and returned<br />
to <strong>the</strong> CRO/sponsor for revision.<br />
In part, because <strong>of</strong> <strong>the</strong> consistency<br />
<strong>of</strong> our approach, repeat contract<br />
negotiations with CROs/sponsors<br />
has resulted in developing<br />
master agreements to support a<br />
process for limited review and<br />
approval. A similar approach has<br />
been taken with non-commercial<br />
sponsors <strong>of</strong> research for review <strong>of</strong><br />
Continued on page 36<br />
<strong>December</strong> 2011<br />
35